NEW YORK (GenomeWeb News) – T2 Biosystems has raised $10.8 million in a Series B financing, the Cambridge, Mass.-based firm said today.
 
T2 will use proceeds from the financing to accelerate development of its portable diagnostics system that combines nanotechnology with miniaturized magnetic resonance technology. The firm said that the technology has been validated for accurately analyzing viruses, bacteria, proteins, hormones, DNA, small molecules, and other diagnostic targets.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.